Evidence map›Paper›PMID 33973155›Full record

ArticleThe patient2021

Correction to: Patient Preferences in Rare Diseases: A Qualitative Study in Neuromuscular Disorders to Inform a Quantitative Preference Study.

A Cecilia Jimenez-Moreno, Eline van Overbeeke, Cathy Anne Pinto, Ian Smith, Jenny Sharpe, James Ormrod, Chiara Whichello, Esther W de Bekker-Grob, Kristin Bullok, Bennett Levitan and 3 more

Open access · hybridAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in The patient, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 95% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 10 institutions in 4 countries.

A Cecilia Jimenez-MorenoTranslational and Clinical Research Institute, Newcastle University, Newcastle-Upon-Tyne, UK. jimenez.moreno.aura.cecilia@gmail.com.
Eline van OverbeekeClinical Pharmacology and Pharmacotherapy, University of Leuven, Leuven, Belgium.
Cathy Anne PintoPharmacoepidemiology Department, Center for Observational and Real-world Evidence, Merck & Co, Inc., Rahway, NJ, USA.
Ian SmithJulius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
Jenny SharpeMuscular Dystrophy UK, London, UK.
James OrmrodSchool of Applied Social Science, University of Brighton, East Sussex, UK.
Chiara WhichelloErasmus School of Health Policy and Management, and Erasmus Choice Modelling Centre, Erasmus University, Rotterdam, The Netherlands.
Esther W de Bekker-GrobErasmus School of Health Policy and Management, and Erasmus Choice Modelling Centre, Erasmus University, Rotterdam, The Netherlands.
Kristin BullokGlobal Patient Safety Department, Eli Lilly & Co., Indianapolis, IN, USA.
Bennett LevitanJanssen Research and Development, Titusville, NJ, USA.
Isabelle HuysClinical Pharmacology and Pharmacotherapy, University of Leuven, Leuven, Belgium.
G Ardine de WitJulius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
Grainne GormanTranslational and Clinical Research Institute, Newcastle University, Newcastle-Upon-Tyne, UK.
Erasmus University Rotterdam · NLKU Leuven · BENewcastle University · GBEli Lilly (United States) · USJanssen (United States) · USMerck & Co., Inc., Rahway, NJ, USA (United States) · USMuscular Dystrophy UK · GBUniversity Medical Center Utrecht · NLUniversity of Brighton · GBUtrecht University · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID33973155
PMCPMC8357777
OpenAlexW3161762678

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.